Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Urate transporter 1 inhibitors patented by Hinova Pharmaceuticals

Dec. 7, 2018

Novel thiazolidine free fatty acid FFA2 receptor agonist with improved properties

Dec. 7, 2018

Novo Nordisk initiates phase II study of once-weekly insulin 287 in type 2 diabetes

Dec. 5, 2018

Placenta organoids to give insights into pregnancy's mysteries

Dec. 5, 2018

Lilly opens phase II study of LY-3209590 for type 2 diabetes

Dec. 4, 2018

Takhzyro subcutaneous injection approved in Europe for the preventive treatment of HAE

Nov. 30, 2018

Cutting carb clutter could transform diabetes treatment

Nov. 30, 2018

Rocket reports preclinical data on gene therapy RP-A501 for Danon disease

Nov. 29, 2018

Sanford Burnham Prebys Medical Discovery Institute identifies ACP1 inhibitors

Nov. 27, 2018

FDA places clinical hold on IND for first U.S. trial of ZGN-1061

Nov. 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...